http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology. http://medicalxpress.com/news/2013-04-high-doses-palmetto-safe-months.html Diseases, Conditions, Syndromes Mon, 29 Apr 2013 20:00:01 EST news286482322 Monitoring pain and providing analgesics to patients in intensive care units (ICUs) during non-surgical procedures, such as turning and washing, can not only reduce the amount of pain but also reduce the number of serious adverse events including cardiac arrest, finds new research in BioMed Central's open access journal Critical Care. http://medicalxpress.com/news/2013-04-pain-movement-intensive.html Other Wed, 17 Apr 2013 20:00:01 EST news285436208 The first controlled clinical trial to test the safety and efficacy of interventional endovascular therapy on the symptoms and progression of multiple sclerosis has found that the intervention, sometimes called the "liberation treatment," which has attracted intense interest in the global MS community, does not improve patient outcomes. In a few cases, the treatment made symptoms worse. http://medicalxpress.com/news/2013-03-ms-patients-benefit-ccsvi-intervention.html Neuroscience Fri, 15 Mar 2013 11:56:24 EST news282567368 The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate. REDUCE results showed that dutasteride decreased the risk of biopsy detectable prostate cancer by 22.8 percent compared to a placebo group, but concerns remained about the drug's effectiveness. Results from a follow-up study are now published in The Journal of Urology. http://medicalxpress.com/news/2013-01-follow-up-prostate-cancer-diagnosis.html Cancer Tue, 22 Jan 2013 07:37:08 EST news278062619 (HealthDay)—For patients with moderate-to-severe hidradenitis suppurativa (HS), a chronic skin disease characterized by painful abscesses, nodules, and draining fistulas in the axilla and groin, treatment with once-weekly adalimumab is associated with improvements in pain and inflammation, according to a study published online Dec. 17 in the Annals of Internal Medicine. http://medicalxpress.com/news/2012-12-adalimumab-relieves-hidradenitis-suppurativa.html Inflammatory disorders Tue, 18 Dec 2012 18:07:14 EST news275076428 (HealthDay)—For patients with ischemic cardiomyopathy (ICM), allogeneic bone marrow-derived mesenchymal stem cells (MSCs) are safe; and delivery of bone marrow mononuclear cells (BMC) to patients with ST-segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI) has no effect on the recovery of left ventricular function, according to two studies published online Nov. 6 in the Journal of the American Medical Association to coincide with presentation at the American Heart Association's Scientific Sessions 2012, held from Nov. 3 to 7 in Los Angeles. http://medicalxpress.com/news/2012-11-aha-allogeneic-stem-cells-ischemic.html Cardiology Wed, 07 Nov 2012 06:10:01 EST news271488294 (HealthDay) -- In kidney-transplant patients with at least one cutaneous squamous-cell carcinoma, switching immunosuppressants (from calcineurin inhibitors to sirolimus) is associated with increased skin cancer-free survival and delayed development of new skin cancers, according to a study published in the July 26 issue of the New England Journal of Medicine. http://medicalxpress.com/news/2012-07-immunosuppressant-skin-cancer-post-transplant.html Cancer Thu, 26 Jul 2012 05:15:04 EST news262498493 (HealthDay) -- A supplement mixture (Souvenaid) containing dietary precursors and specific nutrients can improve memory in drug-naive patients with mild Alzheimer's disease (AD), according to a study published in the July issue of the Journal of Alzheimer's Disease. http://medicalxpress.com/news/2012-07-supplement-mixture-memory-mild-alzheimer.html Alzheimer's disease & dementia Thu, 12 Jul 2012 05:50:02 EST news261287299 A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive Cancer Center researchers conducting the study in cancer patients whose tumors have resisted multiple treatments say the combination demonstrates "promising evidence" of disease control and should be studied in a phase II trial. Their clinical findings and additional data from the study will be presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, June 1 through 5, 2012. http://medicalxpress.com/news/2012-05-phase-temsirolimus-capecitabine-safe-positive.html Cancer Wed, 16 May 2012 18:00:03 EST news256406984 (HealthDay) -- The administration of a single 600-mg dose of albendazole to United States-bound refugees prior to departure from Africa and Southeast Asia reduces the prevalence of intestinal nematodes, according to a study published in the April 19 issue of the New England Journal of Medicine. http://medicalxpress.com/news/2012-04-albendazole-parasite-prevalence-refugees.html Health Thu, 19 Apr 2012 03:40:01 EST news254024424 Cytori Therapeutics announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology. http://medicalxpress.com/news/2012-03-cytori-breast-reconstruction-cell-therapy.html Cancer Mon, 19 Mar 2012 13:24:56 EST news251382289 Cervical preparation with misoprostol reduces major complications of early surgical abortion by almost a third compared with placebo, according to new research published Online First in The Lancet. http://medicalxpress.com/news/2012-03-misoprostol-substantially-complications-early-termination.html Obstetrics & gynaecology Wed, 07 Mar 2012 18:30:04 EST news250359494 The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs and the company will focus instead on new cancer treatments, Geron said Tuesday. http://medicalxpress.com/news/2011-11-embryonic-stem-cell-trial-halted.html Medical research Tue, 15 Nov 2011 10:06:14 EST news240573952 The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns. The trial found that people with IPF receiving a currently used triple-drug therapy consisting of prednisone, azathioprine, and N-acetylcysteine (NAC) had worse outcomes than those who received placebos, or inactive substances. http://medicalxpress.com/news/2011-10-commonly-drug-regimen-idiopathic-pulmonary.html Diseases, Conditions, Syndromes Fri, 21 Oct 2011 17:24:01 EST news238436620 According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate) , is effective not only in decreasing tumor size but also in reducing the severity of side effects that often accompany a cancer diagnosis. While many neuroendocrine cancers are incurable, they grow relatively slowly, and life expectancy is relatively long, making quality of life an important factor in treatment. http://medicalxpress.com/news/2011-09-benefits-radionuclide-therapy-neuroendocrine-tumors.html Cancer Tue, 20 Sep 2011 14:27:17 EST news235747604 Early results suggest that using virtual reality (VR) human-computer interfaces might help adult stroke patients regain arm function and improve their ability to perform standard tasks, when compared to patients who don't use VR. The findings are reported in a new review published in The Cochrane Library. http://medicalxpress.com/news/2011-09-virtual-reality-adults-recover.html Other Wed, 07 Sep 2011 04:14:04 EST news234587061 Results from CREDO-Kyoto PCI/CABG Registry Cohort-2 show that percutaneous coronary intervention (PCI) was associated with significantly higher risk for serious adverse events in patients with triple vessel disease than coronary artery bypass grafting (CABG). The protective effect of CABG for myocardial infarction was described as "especially remarkable". In view of these results, said investigator Dr Hiroki Shiomi from Kyoto University Hospital in Japan, "CABG would still remain the standard treatment option in patients with triple vessel disease, particularly when their SYNTAX scores are high". http://medicalxpress.com/news/2011-08-cabg-pci-patients-triple-vessel.html Cardiology Mon, 29 Aug 2011 11:41:51 EST news233836893 Loyola University Hospital spine surgeon Dr. Alexander Ghanayem is co-author of a landmark editorial challenging the integrity of published industry-sponsored research involving a bone-growth product. http://medicalxpress.com/news/2011-06-landmark-editorial-denounces-poor-spine.html Other Tue, 28 Jun 2011 17:30:42 EST news228501025 Individuals with rheumatoid arthritis taking disease modifying anti-rheumatic drugs, showed significantly less protection from pandemic influenza after receiving the H1N1 vaccine compared to healthy individuals, according to data presented today at the EULAR 2011 Annual Congress. http://medicalxpress.com/news/2011-05-patients-ra-pandemic-influenza-h1n1.html Diseases, Conditions, Syndromes Thu, 26 May 2011 07:59:50 EST news225615576 Giving patients with chronic obstructive pulmonary disease (COPD) newly available oral phosphodiesterase 4 (PDE4) inhibitors, roflumilast or cilomilast, improves lung function and reduces the likelihood of a flareup, but does not increase general quality of life. These are the findings of a new systematic review by Cochrane researchers. http://medicalxpress.com/news/2011-05-phosphodiesterase-inhibitors-marginal-benefits-people.html Diseases, Conditions, Syndromes Wed, 11 May 2011 04:20:01 EST news224305072